We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Proposed Rare Disease Therapies Framework introduces Investigational Marketing Authorisation and compressed development pathways – industry urged to respond
National memorial service held at St Paul's Cathedral to remember Infected Blood victims.
UK Statement for the Explanation of Vote on Lebanon. Delivered at the 79th World Health Assembly in Geneva.
UK National Statement for the 2026 World Heath Assembly as delivered by the UK's Permanent Representative to the WTO and UN, Kumar Iyer.
MHRA announces new programme of events and greater engagement with industries, researchers, local NHS and government in Wales.
There will be a national service at St. Paul’s Cathedral for the infected blood community on Tuesday 19th May 2026.
Michelle Welsh MP appointed as the government's first Maternity Adviser.
Summary from the Global Partnership Conference satellite session in Geneva. Co-hosted by the UK and South Africa on 17 May 2026.
Innovation doesn’t wait for the rules to catch up. The question is whether we can build a system agile and flexible enough to keep pace.
As with any medicine, the MHRA will keep the safety and effectiveness of Vyjuvek under close review.
Safer and faster care for patients as NHS set to introduce single patient record and cut bureaucracy.
New mental health strategy will transform care in England and drive shift from crisis intervention to preventative care.
HIV testing uptake lowest among Black African heterosexual women in sexual health services.
Sussex families to get answers as maternity review scope confirmed.
The MHRA hub in Belfast will strengthen collaboration and engagement with local industry, academia and the healthcare sector.
People with chronic fatigue syndrome, also known as ME, to benefit from world-first genomics study.
Updated safety advice has been issued to strengthen warnings about potential psychiatric and sexual dysfunction linked to finasteride and to provide precautionary advice on dutasteride.
To future-proof the sector and ensure regulation keeps up with scientific and technological developments, the MHRA is consulting on proposed changes to how gene therapies are defined in UK legislation.
New pre-market regulatory requirements for medical devices and in vitro diagnostic devices entering the GB market have been published.
The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in the UK’s thriving £100 billion life sciences industry.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).